Company Overview

SmithKline Beecham Pharma is one of the largest innovative pharmaceutical companies in the world. The mandate of the pharmaceutical organization is health care, defined as the prevention, prediction, diagnosis, treatment, and cure. As one of Canada's fastest growing pharmaceutical companies, SmithKline Beecham has increased its workforce by over 33 percent in the past 3 years, and we plan to add even more people to the SB Team. Since the passage of Bill C-91 for Patent Protection in 1993, the ratio of Research & Development to Sales for SmithKline Beecham Parma has been 10.9 percent. We're proud to have one of the most active pipelines in the industry and expect to bring several new products to market each year for the next five years. In 1996 alone, we brought three new products to market: Kytril, Coreg, and Famvir. SmithKline Beecham Pharma is the world's largest vaccine supplier, producing Havrix and Enfgerix-B for hepatitis A and hepatitis B respectively. SB Pharma recently launched the first combined hepatitis A and B vaccine, Twinrix.

Vision SmithKline Beecham must be an active participant in the health reform debate. We believe an optimal health care system can be achieved through appropriate use of all components. Our role is to ensure the right drug is used at the right time and for the right indication to make our drug programs viable and effective. In doing so, we maximize therapeutic outcomes, increase quality of life, and minimize costs.

A Caring Company -SmithKline Beecham Pharma Canada is recognized as A Caring Company by the Canadian Centre for Philanthropy in honour of our long-standing commitment to re-investing a significant percentage of profits into Canadian charitable and not-for-profit community organizations. We believe it's our corporate responsibility to improve the quality of life communities where we work and conduct business. -SB has twice won the Town of Oakville's Mayor's Award for charitable community giving. -In 1996, we received recognition by the Speaker of the House of Commons Gilbert Parent for our lifesaving product donations to Map International.

Partnerships The health care industry globally, as in our own country, is facing difficult challenges. But these challenges also represent great opportunities. Our products, expertise, financial resources and most importantly, our people are an exceptional base for building sound partnerships for Canada's future.

SB Pipeline & Economic Investment for Canada SmithKline Beecham Pharma will continue to be a major player in the pharmaceutical industry as indicated by the following inventory of our product pipeline. These innovative pharmaceuticals will require continuing our investment in research and development as we bring these drug therapies to market.

A list of our products:

Paxil- treatment for depression, particularly effective when accompanied by symptoms of anxiety

Relafen- treatment of osteo and rheumatoid arthritis

Engerix-B - treatment for the prevention of Hepatitis B

Havrix- the world's first vaccine for Hepatitis A

Famvir- anti-viral for treatment of herpes

Kytril- treatment for chemotherapy induced nausea and vomiting

Coreg- significant improvement for treatment of congestive heart failure with 65% reduction in mortality. * COREG is a trademark of Boehringer Mannhein used under licence by SmithKline Beecham Inc.

Hycamtin- second-line agent for treatment of patients with ovarian cancer

Requip- treatment for patients in the early stages of Parkinson's disease and as adjunct therapy for those in later stages.

Please note: SB Pharma does not manufacture in Canada.

Company Information

Additional Details

Legal Name: GlaxoSmithKline Inc.

Number of Employees: 286

Contacts

Products

• Drug Research
• Research Programs

  Current research programs within each of the key therapeutic areas CARDIOPULMONARY

  • Hypertension
  • Myocardial salvage / ischaemia
  • Atherosclerosis
  • Asthma
  • Chronic obstructive pulmonary disease
  • Congestive heart failure
  • Cerebrovascular disease / stroke
  • Diabetes

  VACCINES

  • Hepatitis C and E
  • Lyme disease
  • Influenza
  • Herpes
  • Malaria
  • Cancer
  • therapeutic vaccines

  NEUROSCIENCES

  • Epilepsy
  • Anxiety
  • Depression
  • Schizophrenia
  • Migraine
  • Alzheimer's disease

  ANTI-INFECTIVES AND BIOLOGICALS

  • Antibacterials
  • Antivirals
  • Antifungals
  • Haematopoiesis

  INFLAMMATION / TISSUE REPAIR / ONCOLOGY

  • Chronic inflammation including osteoarthritis
  • Auto-immune disease including rheumatoid arthritis
  • Prostatic disease
  • Osteoporosis
  • Cancer

Additional Information